manilatimes15m
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
FT836 Preclinical Data Shows Robust Antigen-mediated Expansion, Functional Persistence, and Durable Anti-tumor Activity in ...
manilatimes36m
Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings A/S under the 2024 share repurchase programme
Bagsværd, Denmark, 8 November 2024 - Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of ...
manilatimes17m
Foster Swift Files Appeal on Behalf of Over 70 Michigan Municipalities to Protect Local Control Over Renewable Energy Regulations
Lansing, Mich., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Today, Foster Swift Collins & Smith, P.C., on behalf of more than 70 municipalities across Michigan, has filed an appeal against the Michigan Public ...
manilatimes17m
Matthews International Announces Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call
PITTSBURGH, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its fourth quarter and fiscal year 2024 earnings results after the ...
manilatimes17m
New Providence Acquisition Corp. II Announces Intention to Liquidate
New Providence Acquisition Corp. II (Nasdaq: NPAB) (the 'Company”) announced today that its board of directors (the 'Board”) has determined that the Company will (i) abandon and not implement ...
manilatimes17m
PINTEC ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FIRST HALF OF 2024
Pintec Technology Holdings Limited (Nasdaq: PT) ('Pintec' or the 'Company'), a Nasdaq-listed company providing technology enabled financial and digital services to micro, small and medium enterprises ...